Imbed Biosciences Announces Study Results
Imbed Biosciences announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte Matrix, in complex chronic wounds.
SHINE announces first sales of n.c.a. Lu-177
SHINE announces first sales of its non-carrier-added lutetium-177
Madison-based startup looking to revolutionize computing with a new type of computer chip
Sankaralingam said the chip has the potential to speed up development of artificial intelligence and machine learning, which has been hindered by hardware that can’t keep up.
OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device
OnLume has developed novel FGS imaging technology to illuminate critical anatomy in real-time during surgery to optimize precision, which can lead to improved patient outcomes, reduced morbidity and reduced costs.
SHINE closes $80-million
SHINE closes $80-million Series C financing supported by Fidelity Management and Research Company LLC
Recent Comments